Technological challenges of theranostics in oncology-Reference-Cited by-同舟云学术

Technological challenges of theranostics in oncology

Published:2009-06-18 Issue:4 Volume:3 Page:381-393
ISSN:1753-0059
Container-title:Expert Opinion on Medical Diagnostics
language:en
Short-container-title:Expert Opinion on Medical Diagnostics

Author:

Warenius Hilmar M

Publisher

Informa Healthcare

Subject

Biochemistry, medical,Molecular Medicine,Biomedical Engineering,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17530050902893295

Reference129 articles.

1. Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development

2. Sikora K. Drugs for Cancer. Chapter 5. Responding to the challenge of cancer in Europe. In: Michael P Colemen, Delia-Marina Alexe, Tit Albreht, Martin McKee, editors, Ljubljana. Institute of Public Health of the Republic of Slovenia, 2008. p. 99

3. Designing Phase 0 Cancer Clinical Trials

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemistry, biosynthesis, and theranostics of antioxidant flavonoids and polyphenolics of genus Rhododendron: an overview;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-14

2. Hierarchical design of intelligent α-MnO2-based theranostics nanoplatform for TME-activated drug delivery and T1-weighted MRI;Journal of Drug Delivery Science and Technology;2023-03

3. Fundamental in Polymer-/Nanohybrid-Based Nanorobotics for Theranostics;Nanorobotics and Nanodiagnostics in Integrative Biology and Biomedicine;2022-12-16

4. Technological challenges of theranostics in oncology;Multifunctional Theranostic Nanomedicines in Cancer;2021

5. Conjugated Photosensitizers for Imaging and PDT in Cancer Research;Journal of Medicinal Chemistry;2020-09-29